MEthods for LOcalization of Different Types of Breast Lesions
NCT ID: NCT05559411
Last Updated: 2025-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
7416 participants
OBSERVATIONAL
2023-01-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Several imaging-guided techniques have been developed to guide removal of non-palpable breast lesions, the oldest one being preoperative wire placement under ultrasound or mammographic guidance, usually followed by radiography or ultrasound of removed tissue. Newer techniques, such as intraoperative ultrasound (IOUS), radioguided occult lesion localization (ROLL), radioactive seed localization (RSL), radar reflector-localization (RRL), magnetic seed localization (MSL), and radiofrequency identification (RFID) tags have been introduced as an alternative to wire-guided localization (WGL).
To date, comparative data on the rates of successful lesion removal, negative margins, re-operation rate and patient's comfort depending on the localization technique used are limited. Further, since some of these studies were funded by the manufacturer of the marker examined, a potential bias cannot be excluded. In the vast majority of the available studies, the patient's perspective with regard to discomfort and pain level has not been evaluated.
The aim of the proposed study is to comparatively evaluate different imaging-guided localization methods used for surgical removal of malignant breast lesions with regard to oncological safety and patient-reported outcomes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Spatial Location of Breast Cancer Local Recurrence After Mastectomy
NCT06130111
Study First Step to Virtual Breast Cancer Localization
NCT03214419
A Study to Evaluate the Accuracy of a Breast Cancer Locator (BCL) in Patients With Palpable Cancers
NCT02550210
Locoregional Recurrence of Breast Cancer
NCT05988112
Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging
NCT05809128
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Wire-guided Localization
No interventions assigned to this group
Intraoperative Ultrasound
No interventions assigned to this group
Magnetic Localization
No interventions assigned to this group
Radar Reflector Localization
No interventions assigned to this group
Radiofrequency Localization
No interventions assigned to this group
Radioactive Localization
No interventions assigned to this group
Ink Localization
No interventions assigned to this group
Luminomark Localization
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Malignant breast lesion requiring breast-conserving surgery and imaging-guided localization (either DCIS or invasive breast cancer; multiple or bilateral lesions and the use of neoadjuvant chemotherapy are allowed)
* Planned surgical removal of the lesion using one or more of the following imaging-guided localization techniques:
* Wire-guided localization
* Intraoperative ultrasound
* Magnetic localization
* Radioactive seed localization
* Radioguided Occult Lesion Localization (ROLL)
* Radar localization
* Radiofrequency identification (RFID) tag localization
* Ink/carbon localization
* Female / male patients ≥ 18 years old
Exclusion Criteria
* Patients requiring mastectomy as first surgery
* Surgical removal without imaging-guided localization
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
iBRA-NET
UNKNOWN
European Breast Cancer Research Association of Surgical Trialists
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Schleswig-Holstein Campus Lübeck
Lübeck, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Maggie Banys-Paluchowski, MD, PhD
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EUBREAST-4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.